These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4808220)

  • 1. Self-prescription of methadone: inpatient and outpatient addict populations.
    Angle HV; Strelinger RW; Parwatikar S
    Proc Natl Conf Methadone Treat; 1973; 1():682-9. PubMed ID: 4808220
    [No Abstract]   [Full Text] [Related]  

  • 2. Daily visits, "no-take-home" methadone, and seven-day-per-week operation: patient retention and employment patterns subsequent to cessation of "take-home" privileges in a methadone maintenance clinic.
    Patch VD; Fisch A; Levine ME; McKenna GJ; Raynes AE
    Proc Natl Conf Methadone Treat; 1973; 2():1273-7. PubMed ID: 4808279
    [No Abstract]   [Full Text] [Related]  

  • 3. [Anticipated effects of experimental heroin prescription on the method of administration and the use of other drugs].
    Benschop A; Hendriks VM; Blanken P
    Ned Tijdschr Geneeskd; 1997 Feb; 141(6):292-5. PubMed ID: 9148165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Referral decision-making in a multi-modality system".
    Savitz LD; File K; McCahill TW
    Proc Natl Conf Methadone Treat; 1973; 1():158-68. PubMed ID: 4808143
    [No Abstract]   [Full Text] [Related]  

  • 5. Heroin prescription in Europe: heroin treatment is a pragmatic way of reducing the risks associated with addiction.
    Prescrire Int; 2003 Dec; 12(68):235-6. PubMed ID: 14986702
    [No Abstract]   [Full Text] [Related]  

  • 6. Follow-up evaluations of inpatient detoxification patients.
    Strelinger RW; Angle HV; Crawford J; Yaffe GJ; Parwatikar S
    Proc Natl Conf Methadone Treat; 1973; 1():464-70. PubMed ID: 4808186
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of drug addiction in two different communities. Comparative review.
    Ruiz P; Lowinson JH; Marcus N; Langrod J
    N Y State J Med; 1973 Sep; 73(18):2244-7. PubMed ID: 4517128
    [No Abstract]   [Full Text] [Related]  

  • 8. [Dutch research on the effectiveness of medical prescription of heroin; background, research design and preliminary results].
    van den Brink W; Hendriks VM; Blanken P; van Ree JM
    Ned Tijdschr Geneeskd; 2000 Jan; 144(3):108-12. PubMed ID: 10674115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heroin and methadone prescriptions from a London drug clinic over the first 15 years of operation (1968-1983): old records examined.
    Strang J; Sheridan J
    Subst Use Misuse; 2006; 41(9):1227-38. PubMed ID: 16861174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Buprenorphine replacement therapy: a confirmed benefit.
    Prescrire Int; 2006 Apr; 15(82):64-70. PubMed ID: 16604748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physician involvement in drug abuse services in Forsyth County.
    Savitz D; Butler E; Mueller JC; Spencer WJ
    N C Med J; 1973 Jun; 34(6):437-42. PubMed ID: 4514411
    [No Abstract]   [Full Text] [Related]  

  • 12. The general practitioner and drug dependence.
    Paul AH
    N Z Med J; 1972 Oct; 76(485):278-9. PubMed ID: 4509220
    [No Abstract]   [Full Text] [Related]  

  • 13. [Risk factors associated with continued heroin use during methadone maintenance treatment in Guizhou province, China].
    Liu EW; Wu ZY; Liang T; Shen LM; Zhong H; Wang B; Roger D
    Zhonghua Yu Fang Yi Xue Za Zhi; 2008 Dec; 42(12):875-8. PubMed ID: 19141219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
    Banta-Green CJ; Maynard C; Koepsell TD; Wells EA; Donovan DM
    Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dutch investigators recommend prescription of heroin to addicts.
    van Kolfschooten F
    Lancet; 2002 Feb; 359(9306):590. PubMed ID: 11867123
    [No Abstract]   [Full Text] [Related]  

  • 16. Depression and self-concept as variables in the differential response to methadone maintenance combined with therapy.
    Fisch A; Patch VD; Greenfield A; Raynes AE; McKenna G; Levine M
    Proc Natl Conf Methadone Treat; 1973; 1():440-6. PubMed ID: 4808182
    [No Abstract]   [Full Text] [Related]  

  • 17. Patient and physician characteristics in relation to clinical decision making in methadone maintenance treatment.
    Mitchell TB; Dyer KR; Peay ER
    Subst Use Misuse; 2006; 41(3):393-404. PubMed ID: 16467013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interagency contract: a cooperative effort in community methadone programming.
    Stegbauer VT
    Proc Natl Conf Methadone Treat; 1973; 2():1259-63. PubMed ID: 4808276
    [No Abstract]   [Full Text] [Related]  

  • 19. ASHP guidelines for institutional use of controlled substances.
    Am J Hosp Pharm; 1974 Jun; 31(6):582-8. PubMed ID: 4407475
    [No Abstract]   [Full Text] [Related]  

  • 20. Internal indicators for the management and prognosis of patients in a methadone maintenance program (internal states self-report scale).
    Fisch A; Patch VD; Greenfield A; Raynes AE; McKenna G; Levine M
    Proc Natl Conf Methadone Treat; 1973; 1():433-9. PubMed ID: 4808181
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.